Reimbursement, Pre-Billing Specialist (Eligibility)
Boost your chances before you apply.
Castle Biosciences
Friendswood, TX, US
Summary
Responsible for assigning medical insurance plans and performing eligibility verification checks for new patient accounts. The role involves resolving eligibility issues and managing the submission and follow-up of prior authorizations.
Job Description
Castle Biosciences Earns "Top Workplaces USA Award" for Phoenix, Pittsburgh, and Friendswood!
Learn more at www.CastleBiosciences.com
Castle Biosciences Inc. is growing, and we are looking to hire a full-time Reimbursement, Pre-Billing Specialist working remotely from your home office based in the USA with a start date of September 14, 2026.
Why Castle Biosciences?
Exceptional Benefits Package:
- Salary Range: $40,000 - $42,000. Final salary is based on Experience and Education levels.
- Excellent Annual Salary + 20% Bonus Potential
- 20 Accrued PTO Days Annually
- 10 Paid Holidays
- 401K with 100% Company Match up to 6%
- 3 Health Care Plan Options + Company HSA Contribution
- Company Stock Grant Upon Hire
- $75/month reimbursement for internet service
A DAY IN THE LIFE OF A Pre-Billing Specialist (Eligibility)
This individual will be responsible for assigning medical insurance plans and performing eligibility verification checks on new patient accounts entering the billing system. They will resolve eligibility issues by contacting providers and patients to obtain updated information, and will submit and follow up on assigned prior authorizations. This role will spend the most time assigning medical insurance plans, verifying eligibility, resolving issues, and managing prior authorization submissions and follow-ups.
REQUIREMENTS
- High school Diploma, GED, or equivalent work experience.
- Minimum of two years of health insurance eligibility and prior authorization experience.
- Experience collaborating with patients, providers, and insurance plans to complete the pre-billing process.
- Experience researching and utilizing payor websites.
- Certification in Medical Billing and/or Coding or equivalent experience.
- Must demonstrate the ability to type 35 WPM with 90% or higher accuracy.
*Please see the full job description at the end of the job ad.
TRAVEL REQUIREMENTS
- <5% as needed for training and meetings.
SCHEDULE
- Monday - Friday, 8:00 AM to 5:00 PM, non-exempt position, working remotely from your home office based in the USA.
READY TO JOIN OUR BIOTECH TEAM?
We truly appreciate your time. If this feels like the right opportunity for you, we'd love for you to complete our mobile-friendly application. We're excited to learn more about you and look forward to connecting soon!
Castle Biosciences Awards and Research Developments!
WORK AUTHORIZATION
All candidates must be legally authorized to work in the United States. Currently, Castle Biosciences does not sponsor H-1B visas, OPT, or employment-related visas.
ABOUT CASTLE BIOSCIENCES INC.
At Castle, it all comes down to people. After all, disease doesn't just happen - it happens to people. We believe that disease management and treatment decisions can be better informed through a person's unique biology, which is revealed through the scientific rigor of our innovative, laboratory-developed tests. We are committed to empowering healthcare providers and patients with the goal of improved outcomes.
Every employee at Castle has an impact on patient care, and we work to ensure that everyone finds their work to be both challenging and rewarding. We behave with integrity and treat our colleagues with respect and kindness. Our culture fosters an environment of trust, transparency, and collaboration. We prioritize and encourage internal growth and professional development.
Castle Biosciences is an equal opportunity employer as to all protected groups, including protected veterans and individuals with disabilities.
If you have a disability and you believe you need a reasonable accommodation in order to search for a job opening or to submit an online application, please e-mail [email protected].
This email was created exclusively to assist disabled job seekers whose disability prevents them from being able to apply online. Only messages left for this purpose will be returned. Messages left for other purposes, such as following up on an application or technical issues not related to a disability, will not receive a response.
** No third-party recruiters, please
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.
The Company’s innovative portfolio of commercial and pipeline tests targets unmet clinical need along the patient care continuum. Castle currently markets five proprietary tests designed to answer clinical questions and address treatment plan challenges facing physicians in dermatologic cancers, Barrett’s esophagus, and uveal melanoma.
DecisionDx®-Melanoma, Castle’s test for invasive cutaneous melanoma, is a proprietary gene expression profile (GEP) test that uses an individual patient’s tumor biology to predict the risk of metastasis or recurrence, as well as the risk of sentinel lymph node positivity, independent of traditional staging factors.
DecisionDx®-SCC is the Company’s GEP test that predicts the risk of metastasis in patients with cutaneous squamous cell carcinoma, who have one or more risk factors.
MyPath® Melanoma provides a highly accurate, objective result to aid dermatopathologists and dermatologists in characterizing suspicious pigmented lesions.
TissueCypher® Barrett’s Esophagus is the world’s first precision medicine test designed to predict future development of esophageal cancer in patients with Barrett’s esophagus.
DecisionDx®-UM, the standard of care in uveal melanoma staging, is Castle's GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer.
Castle Biosciences is based in Friendswood, TX, (a suburb of Houston) and has laboratory operations in Phoenix, AZ, and Pittsburgh, PA.
Founded
2008
Company size
1,001-5,000 employees
Industry
Biotechnology Research
Org type
Public Company
Headquarters
Friendswood, Texas
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.
The Company’s innovative portfolio of commercial and pipeline tests targets unmet clinical need along the patient care continuum. Castle currently markets five proprietary tests designed to answer clinical questions and address treatment plan challenges facing physicians in dermatologic cancers, Barrett’s esophagus, and uveal melanoma.
DecisionDx®-Melanoma, Castle’s test for invasive cutaneous melanoma, is a proprietary gene expression profile (GEP) test that uses an individual patient’s tumor biology to predict the risk of metastasis or recurrence, as well as the risk of sentinel lymph node positivity, independent of traditional staging factors.
DecisionDx®-SCC is the Company’s GEP test that predicts the risk of metastasis in patients with cutaneous squamous cell carcinoma, who have one or more risk factors.
MyPath® Melanoma provides a highly accurate, objective result to aid dermatopathologists and dermatologists in characterizing suspicious pigmented lesions.
TissueCypher® Barrett’s Esophagus is the world’s first precision medicine test designed to predict future development of esophageal cancer in patients with Barrett’s esophagus.
DecisionDx®-UM, the standard of care in uveal melanoma staging, is Castle's GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer.
Castle Biosciences is based in Friendswood, TX, (a suburb of Houston) and has laboratory operations in Phoenix, AZ, and Pittsburgh, PA.
Founded
2008
Company size
1,001-5,000 employees
Industry
Biotechnology Research
Org type
Public Company
Headquarters
Friendswood, Texas